Episode 9
The New Politics of Big Tech, and Equity in Clinical Trials ft. Jill Fisher
August 14, 2020
In this episode, Shobita and Jack discuss the recent US congressional hearings with the Big Tech CEOs, and the curious role that behavioral scientists have played in the UK's COVID-19 response. They also chat with Jill Fisher, Professor of Social Medicine at University of North Carolina—Chapel Hill and recent author of Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals, about the "healthy volunteers" who participate in clinical trials—including for COVID-19—and their exploitation.
Related links:
Jill Fisher (2020). Adverse Events: Race Inequality, and the Testing of New Pharmaceuticals. NYU Press.
Carl Elliott (2020). Review of Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals. The New York Review of Books.
Carl Elliott (2007). "Guinea-pigging." The New Yorker. December 31.
Laura Stark (2020). Review of Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals. The New Republic.
BBC Radio 4 Analysis (2020). "Behavioral Science and the Pandemic."
Sonia Sodha (2020). "Bias in ‘the science’ on coronavirus? Britain has been here before." The Guardian. July 23.
Monica Anderson (2020). "Most Americans say social media companies have too much power, influence in politics." Pew Research Center.